Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplant in HIV-infected patient with acute myeloid leukaemia

2018 ◽  
Vol 53 (12) ◽  
pp. 1518-1521 ◽  
Author(s):  
A. Kanellopoulos ◽  
M. Kaparou ◽  
E. Xenou ◽  
S. Paneesha ◽  
B. Kishore ◽  
...  
Keyword(s):  
Stem Cell ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Infected Patient ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Reduced Intensity ◽  
Acute Myeloid

Outcomes of non‐myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission

2021 ◽  
Vol 51 (11) ◽  
pp. 1954-1958
Author(s):  
Phillip C. Nguyen ◽  
Kate Manos ◽  
Chun Y. Fong ◽  
Anthony P. Schwarer ◽  
Ing S. Tiong ◽  
...  
Keyword(s):  
Stem Cell ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Older Patients ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
First Remission ◽  
Acute Myeloid

scholarly journals Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia

2017 ◽  
Vol 178 (4) ◽  
pp. 592-602 ◽  
Author(s):  
Lene Karlsson ◽  
Erik Forestier ◽  
Henrik Hasle ◽  
Kirsi Jahnukainen ◽  
Ólafur G. Jónsson ◽  
...  
Keyword(s):  
Stem Cell ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Acute Myeloid

scholarly journals A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant

2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Claire Horgan ◽  
Alexandros Kanellopoulos ◽  
Shankara Paneesha ◽  
Bhuvan Kishore ◽  
Richard Lovell ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Stem Cell ◽  
Myeloid Leukemia ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Unique Case ◽  
Reduced Intensity ◽  
Acute Myeloid ◽  
Donor Lymphocyte Infusions

A unique case of primary refractory FLT3-itd mutated acute myeloid leukemia in an elderly patient, who achieved completed morphological remission, and FLT3-itd negativity, following 9 cycles of azacitadine in combination with escalating doses of donor lymphocyte infusions following relapse 18 months post reduced intensity HLAA mismatch Campath conditioning allogeneic stem cell transplant.

Sign in / Sign up

Export Citation Format

Share Document